SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 9, 1998
DERMA SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 1-31070 23-2328753
(State or other jurisdiction (Commission (IRS employer
of incorporation) File Number) identification number)
214 Carnegie Center, Suite 100
Princeton, NJ 08540
(609) 514-4744
(Address including zip code and telephone
number, of principal executive offices)
<PAGE>
ITEM 5. OTHER EVENTS
Incorporated by reference is the press release issued February 13, 1998
concerning the Registrant's announcement of the appointment of Timothy J.
Patrick to its Board of Directors on February 9, 1998, attached hereto as
Exhibit 99.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Not applicable
(b) Not applicable
(c) Exhibits:
Number Description
------ -----------
99 Press release issued February 13, 1998.
<PAGE>
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
DERMA SCIENCES, INC.
Date: February 19, 1998 By:/s/ Richard S. Mink
--------------------
Richard S. Mink
Chief Operating Officer
FOR RELEASE FEBRUARY 13, 1998 AT 7:30 AM EST
Contact: Allen & Caron Inc. or Edward J. Quilty, Chairman
Mark Alvino (investors) Derma Sciences, Inc.
212/698-1360 609/514-4744
Owen Daley (media)
714/252-8440
TIMOTHY PATRICK APPOINTED TO DERMA SCIENCES BOARD
PRINCETON, NJ (February 13, 1998)....Derma Sciences, Inc.(Nasdaq: DSCI)
today announced that Timothy J. Patrick, 39, has been appointed to its Board of
Directors, replacing Herbert Grossman, RPH, who recently passed away. A veteran
healthcare industry executive, Patrick is currently President and CEO of
Atlanta-based Proxima Therapeutics, Inc., a medical device company developing
proprietary site-specific delivery systems for the treatment of solid tumors. He
previously served as President of Gesco International, an Atlanta-based
subsidiary of MedChem Products, that manufactured and marketed PICC vascular
access catheters. Prior to that he was President of Irvine, CA-based Central
Admixture Pharmacy Services, a business unit of McGaw, Inc. that provided
patient-specific intravenous solution products to hospitals and home care
companies.
Derma Sciences Chairman Edward J. Quilty commented, "Tim Patrick brings
to the Board a valuable combination of senior executive experience in the
healthcare industry and a creative, market-oriented approach to business. He
will add measurably to the Board's resources, and the management and Directors
of Derma Sciences look forward to calling on Tim's experience and insight as the
Company builds for the future."
Patrick graduated from Miami University, Oxford, OH, in 1981 with a B.S.
in biology. He resides with his wife and three sons in Atlanta.
Derma Sciences, Inc. is engaged in the development, marketing and sales
of topical nutrient-based wound care products, using its proprietary zinc
formulation for the management of certain chronic, non-healing skin ulcerations
such as pressure and venous ulcers, surgical incisions and burns.
